Project
Bringing a prophylactic Ebola vaccine to licensure (EBOVAC3).
Researchers
- Pierre Van Damme (Promoter)
Vaccine & Infectious Disease Institute (VAXINFECTIO)
Duration: 1 Jun 2018 → Today - Pierre Van Damme (Promoter)
Centre for the Evaluation of Vaccination (CEV)
Duration: 1 Jun 2018 → Today - Jean-Pierre Van geertruyden (Co-promoter)Duration: 1 Jan 2019 → Today
- Hilde Revets (Co-promoter)
Vaccine & Infectious Disease Institute (VAXINFECTIO)
Duration: 1 Jun 2018 → 2 Jun 2019 - Jean-Pierre Van geertruyden (Co-promoter)
Epidemiology and social medicine (ESOC)
Duration: 1 Jun 2018 → 31 Dec 2018
Project partners
- Vaccine & Infectious Disease Institute (VAXINFECTIO) (Research group)
Project owner
From1 Jun 2018 → 31 Dec 2018 - Epidemiology and social medicine (ESOC) (Research group)From1 Jun 2018 → 31 Dec 2018
- Centre for the Evaluation of Vaccination (CEV) (Research group)
Project owner
From1 Jan 2019 → Today - Global Health Institute (GHI) (Research group)From1 Jan 2019 → Today
Funding
1 - 1 of 1 results
- Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing(Principal funding)
Funding party: European Commission
Policy level funding: European
Publications
- Longitudinal assessment of an Ebola vaccine trial understanding among healthcare providers in the Democratic Republic of the Congo(2024)
Authors: Trésor Zola Matuvanga, Ynke Larivière, Gwen Lemey, Bernard Osangir, Joachim Mariën, Solange Milolo, Rachel Meta, Junior Matangila, Vivi Maketa, Patrick Mitashi, et al.
- Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study pr(2021)
Authors: Ynke Larivière, Tresor Zola, Elke Stoppie, Vivi Maketa, Junior Matangila, Patrick Mitashi, Jessie De Bie, Hypolite Muhindo-Mavoko, Jean-Pierre Van geertruyden, Pierre Van Damme
- Conducting an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo(2023)
Authors: Ynke Larivière, Trésor Zola Matuvanga, Gwen Lemey, Bernard Osangir, Paul Peter Vermeiren, Solange Milolo, Rachel Meta, Primo Kimbulu, Emmanuel Esanga, Junior Matangila, et al.
- Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo(2024)
Authors: Ynke Larivière, Trésor Zola Matuvanga, Bernard Osangir, Solange Milolo, Rachel Meta, Primo Kimbulu, Cynthia Robinson, Michael Katwere, Chelsea McLean, Gwen Lemey, et al.
- Use of iris scanning for biometric recognition of healthy adults participating in an Ebola vaccine trial in the Democratic Republic of the Congo(2021)
Authors: Tresor Zola Matuvanga, Ginger Johnson, Ynke Larivière, Emmanuel Esanga Longomo, Junior Matangila, Vivi Maketa, Bruno Lapika, Patrick Mitashi, Paula Mc Kenna, Jessie De Bie, et al.
- Within-host modeling to measure dynamics of antibody responses after natural infection or vaccination(2023)
Authors: Irene García-Fogeda, Hajar Besbassi, Ynke Larivière, Benson Ogunjimi, Steven Abrams
- Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo(2022)
Authors: Trésor Zola Matuvanga, Ynke Larivière, Gwen Lemey, Jessie De Bie, Solange Milolo, Rachel Meta, Emmanuel Esanga, Paul Peter Vermeiren, Séverine Thys, Jean-Pierre Van geertruyden, et al.
- Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo(2021)
Authors: Gwen Lemey, Ynke Larivière, Tresor Matuvanga Zola, Vivi Maketa, Junior Matangila, Patrick Mitashi, Paul Peter Vermeiren, Séverine Thys, Jessie De Bie, Hypolite Mavoko Muhindo, et al.